I. Introduction
Screening involves scanning and evalution of test compound. It always involves a test or a group of tests, which will permit the detection of physiological activities of compound. The chief purpose of screening, are to demonstrate, whether the new group of compounds have useful pharmacological properties. There are different types of screening :( i) Simple screening: When one or two tests are used to find substances having a particular property, no need a battery of tests in which the results of one test may depend on those of another test. For example: a single test for the concentration of sugar in the blood might be used to screen compounds for hypoglycemic activities. ii) Blind screening: If a new series of chemical substances isolated from natural source or through synthesis. There may be no information on its pharmacological activities, then blind screening is done. (iii) Programmed screening: When a series of compounds is to be investigated for some pharmacological effects, this type of screening is done. Bioassay is defined as the estimation of the potency of an active principle in a unit quantity of preparation or detection and measurement of the concentration of the substance in a preparation using biological methods (i.e. observation of pharmacological effects on living tissues, microorganisms or immune cells or animal). A battery of cell-and enzyme-based marker systems, have been used for prevention of carcinogenesis in vivo. These systems include modulation of drug metabolism (inhibition of Cyp1A activity, induction of NAD(P)H:quinone reductase (QR) activity in Hepa1c1c7 murine hepatoma cell culture), determination of radical scavenging (DPPH scavenging) and antioxidant effects (scavenging of superoxide anion-, hydroxyl-and peroxyl-radicals), anti-inflammatory mechanisms (inhibition of lipopolysaccharide (LPS)-mediated nitric oxide (NO) generation by inducible NO synthase (iNOS) in Raw 264.7 murine macrophages, cyclooxygenase-1 (Cox-1) inhibition), and anti-tumor promoting activities (inhibition of phorbol ester-induced ornithine decarboxylase (ODC) activity in 308 murine keratinocytes). 1 In vitro methods have been largely used nowadays in screening of anti-cancer drugs, because of certain advantages over in vivo methods. In Vitro methods are less expensive, less time consuming, less complicated, mostly reproducible, & no requirement of any living person or animal. 
II.
Cell Culture Assays
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Maintainence of cell lines: HeLa (human epithelial cervical carcinoma) and MCF-7 (human breast adenocarcinoma) cells procured from diseased tissues. These are grown in 25 cm 2 tissue culture flasks containing suitable media. 3 These cells are maintained by using Dulbecco's Minimum Essential Medium (DMEM) supplemented with 10% FBS, 1% Penicillin Streptomycin at 37ºC in CO 2 incubator. Sub culturing is done in 25cm 2 tissue culture flasks, and cells are studied. Sub-culturing process of cell lines is done by a method called trypsinization. Here, cells are dislodged from the culture flasks by various techniques. The culture media from the flasks containing monolayer culture is aspirated and washed with sterile phosphate buffered saline (PBS). Subsequently, 2 mL of 0.1% trypsin-EDTA solution is added & flask is kept in incubator for [2] [3] min. This allows the cells to be detached. The flask is taken from the incubator and the cell detachment is confirmed by observing under an inverted microscope. Once the cells are completely detached from the flasks, 3 mL of DMEM media containing 10% FBS is added and mixed well. Cell viability is checked with a small sample of the suspension by trypan blue dye exclusion test. This method is used to obtain a single cell suspension from a monolayer culture. Preservation of the tumor cells: Tumor cells from the first and second passage of transplantation are stored in liquid nitrogen in cryovials containing media supplemented with 20% serum and 10% DMSO as preservative at a concentration of 10 6 cells/mL. This constitutes the tumor bank. After every 10 passages, that tumor cell line is discarded and new passage is started using the original tumor cells from the tumor bank.
III. Brine Shrimp Lethality Assay
Principle: A method utilising brine shrimp (Artemia salina), is a simple bioassay for natural product research. The procedure determines lethal concentrations of active compounds in brine medium. The activities of a broad range of active compounds are manifested as toxicity to the shrimp. The method is rapid, reliable and has been used for over thirty years in toxicological studies. A positive correlation exists between brine shrimp lethality and human carcinoma. Hatching chamber: It is made of glass, with aluminum lid on top. The chamber is divided into two equal parts with the help of a laminated plywood divider having a number of holes of 2 mm size. One of the compartments is illuminated with a lamp (60 watts), while the other is darkened. Both the chambers are aerated. Drug sample preparation: Samples of the drug are prepared by dissolving 5mg of drug in 10 ml of DMSO to get 500 µM stock solution. From this stock final drug concentration are prepared and volume is made up to 5ml (in 7 ml vial capacity) with solution which contain specific volume of brine and yeast suspension to get the final drug conc. Three replicates were prepared for each dose level. Control vials are prepared by adding equal volumes of distilled water. Bioassay Method: The 5.0L of artificial sea water is added to the special chamber 0.20mg of the eggs are washed with water and then these eggs are sprinkled into the compartment which is darkened. Aeration is provided in compartments. After 48 hrs, the phototropic nauplli are collected and are used for bioassay. Nauplli are drawn in a pipette along with water, and ten of such shrimps are transferred to each sample vial after they are counted in the stem of pipette against lighted background. The artificial sea water is added to each vial to make upto 5ml. A drop of dry yeast suspension (3 mg in 5-ml sea water) is added to each vial as food for shrimps. The vials are maintained under illumination. After 24hrs, survivors are counted by using 3X magnifying glass, and the percent deaths and LD 50 values are calculated.
IV. MTT assay
Principle: Succinate-tetrazolium reductase system belongs to the mitochondrial respiratory chain functioning in metabolically active cells. MTT, [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide], is reduced to formazan by viable cells with the help of "Succinate-tetrazolium reductase" system. Formazan is largely impermeable to cell membranes, thus resulting in its accumulation within the healthy cells. Dimethyl sulphoxide (DMSO) on reacting with formazan gives purplish color. The optical density (OD) of purple colored solution developed is read using a conventional ELISA plate reader at 590nm (maximum absorbance). This ability of cells to reduce MTT provides an indication of the mitochondrial integrity and activity, interpreted as a measure of quantitative assessment and viability of cells. 
V. Determination of Total Cell Protein Content by Sulphorhodamine B (Srb)
Principle: SRB is a bright pink aminoxanthene dye with two sulfonic groups. Under mild acidic conditions, SRB binds to protein basic amino acid residues in TCA (Trichloro acetic acid) fixed cells to provide a sensitive index of cellular protein content. Color development in SRB assay is rapid, stable and visible. The developed color can be measured over a broad range of visible wavelength in either spectrophotometer or an ELISA plate reader. When TCA-fixed and SRB stained samples are air-dried, they can be stored indefinitely without deterioration.
Reagents:
The reagents used in this assay are:
• SRB dye (0.054% prepared in 1% acetic acid) • 10 mM TRIS base • 50 % TCA (Trichloro acetic acid) • Microplate reader (ELISA Reader) Procedure: Cells are seeded onto 96-well microtiter plates at a concentration of (1X10 5 cell/mL). The plates are incubated at 36.5 o C in humidified CO 2 (10%) incubator for 24 hr. About10μL of test compound is added to these plates. Plates are incubated for next 48-72hr at 36.5 o C in humidified CO 2 (10%) incubator. After incubation medium is removed for the wells and 200μL of 10% TCA is added. After 30 minutes, plates are washed gently under tap water and air dried at room temperature. Then 100μL SRB reagent is added into each well and left for 15minutes. 1% acetic acid is used to remove SRB. After air drying, 0.2ml of 10mM unbuffered TRIS base is added, and absorbance is measured at 540 nm. ED 50 value of compounds possessed cytotoxic activity is calculated by following formula:
Percentage growth inhibition = 100-(AbsTest/AbsControl) X 100
VI. Trypan Blue Dye Exclusion Assay
Principle: It is a short-term in vitro screening system for test compounds. A living cell membrane has the ability to prevent the entry of certain dyes into the cell. Hence, the viable cells remain unstained and can be easily distinguished from the dead cells that take up the dye and appear blue under the microscope. • 1 mg Ethidium bromide dissolved in 1 mL milli-equivalent water • 1 mg Acridine orange dissolved in 1 mL meq water Procedure: MCF-7 cells (1X10 6 ) are seeded in T-25 flask in 5 mL of DMEM (Dulbecoo's modified eagle's medium) supplemented with 10% FBS and allowed to attach for 24h.Then the petroleum ether, ethyl acetate, butanolic and alcoholic extracts are added at their IC50 (determined from SRB assay) to the flasks, and the flasks are kept in incubator for 48 hrs at 37 °c. Media containing floating cells is removed into centrifuge tubes and centrifuged at 1000 rpm for 5 min. Cells are washed with PBS and stored at 4⁰C in ethanol. To 20 μl of the cell suspensions, 5μl of ethidium bromide and 5μl of acridine orange solutions are added and kept for 5 minutes.
A small aliquot of this solution is placed on a slide and observed under the fluorescent microscope (blue filter). TRIZMA base -54gms Boric acid -25.1gms 0.5M EDTA solution -20mL Procedure: MCF-7 cells (1X10 6 ) are seeded in T-25 flask in 5 mL of DMEM medium supplemented with 10% FBS and allowed to attach for 24h.The petroleum ether, ethyl acetate, butanolic and ethanolic extracts are added at their IC50 (determined from SRB assay) to the flasks and the flasks are kept in incubator for 48 hrs at 37 °C. Media containing floating cells is removed into centrifuge tubes and centrifuged at 1000 rpm for 5 min. 300 μl of lysis buffer is added to flask containing attached cells monolayer. The cells are scraped and added to the cell pellet in the tubes obtained after centrifugation. The cells pellet in lysis buffer is incubated at 50 °C for 1 h, followed by addition of RNAse solution. After that cells again kept at 50 °C or 1 h. A brief exposure at 65 °C for 2 min is followed to destroy the RNA. The processed cells are then cooled at room temperature, diluted with 30% glycerol in the ratio1:1 and loaded into the wells of agarose gel (1.5% in TBE buffer). Electrophoresis is carried by using Bio-Rad electrophoresis unit out at 60 V, 400 mA for 180 min using TBE buffer.
VII. D NA Fragmentation Assay

VII. Conclusion
We have discussed various in-vitro screening methods used in assessment of cytotoxicity of different chemotherapeutic drugs. The advantages of in-vitro methods over in-vitro methods demand more research in near future.
